Tissue Diagnostics Instrument Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4115568
- 137 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Tissue Diagnostics Instrument market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Tissue Diagnostics Instrument market segmented into
Slide-staining Systems
Scanners
Tissue-processing Systems
Others
Based on the end-use, the global Tissue Diagnostics Instrument market classified into
Breast cancer
Gastric cancer
Lymphoma
Prostate cancer
Non-small cell lung cancer
Others
Based on geography, the global Tissue Diagnostics Instrument market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Roche (Switzerland)
Danaher (US)
Thermo Fisher Scientific (US)
Abbott (US)
Agilent Technologies (US)
Merck (Germany)
Sakura Finetek Japan (Japan)
Abcam (UK)
BD (US)
QIAGEN (Netherlands)
Sienna Cancer Diagnostics (Australia)
Royal Philips (Netherlands)
A. Menarini Diagnostics (Italy)
Cell Signaling Technology (US)
Enzo Life Sciences (US)
Master Diagnóstica (Spain)
TissueGnostics (Austria)
Bio SB (US)
MedImmune (US)
Cernostics (US)
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL TISSUE DIAGNOSTICS INSTRUMENT INDUSTRY
2.1 Summary about Tissue Diagnostics Instrument Industry
2.2 Tissue Diagnostics Instrument Market Trends
2.2.1 Tissue Diagnostics Instrument Production & Consumption Trends
2.2.2 Tissue Diagnostics Instrument Demand Structure Trends
2.3 Tissue Diagnostics Instrument Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Slide-staining Systems
4.2.2 Scanners
4.2.3 Tissue-processing Systems
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Breast cancer
4.3.2 Gastric cancer
4.3.3 Lymphoma
4.3.4 Prostate cancer
4.3.5 Non-small cell lung cancer
4.3.6 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Slide-staining Systems
5.2.2 Scanners
5.2.3 Tissue-processing Systems
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Breast cancer
5.3.2 Gastric cancer
5.3.3 Lymphoma
5.3.4 Prostate cancer
5.3.5 Non-small cell lung cancer
5.3.6 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Slide-staining Systems
6.2.2 Scanners
6.2.3 Tissue-processing Systems
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Breast cancer
6.3.2 Gastric cancer
6.3.3 Lymphoma
6.3.4 Prostate cancer
6.3.5 Non-small cell lung cancer
6.3.6 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Slide-staining Systems
7.2.2 Scanners
7.2.3 Tissue-processing Systems
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Breast cancer
7.3.2 Gastric cancer
7.3.3 Lymphoma
7.3.4 Prostate cancer
7.3.5 Non-small cell lung cancer
7.3.6 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Slide-staining Systems
8.2.2 Scanners
8.2.3 Tissue-processing Systems
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Breast cancer
8.3.2 Gastric cancer
8.3.3 Lymphoma
8.3.4 Prostate cancer
8.3.5 Non-small cell lung cancer
8.3.6 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Slide-staining Systems
9.2.2 Scanners
9.2.3 Tissue-processing Systems
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Breast cancer
9.3.2 Gastric cancer
9.3.3 Lymphoma
9.3.4 Prostate cancer
9.3.5 Non-small cell lung cancer
9.3.6 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Roche (Switzerland)
10.1.2 Danaher (US)
10.1.3 Thermo Fisher Scientific (US)
10.1.4 Abbott (US)
10.1.5 Agilent Technologies (US)
10.1.6 Merck (Germany)
10.1.7 Sakura Finetek Japan (Japan)
10.1.8 Abcam (UK)
10.1.9 BD (US)
10.1.10 QIAGEN (Netherlands)
10.1.11 Sienna Cancer Diagnostics (Australia)
10.1.12 Royal Philips (Netherlands)
10.1.13 A. Menarini Diagnostics (Italy)
10.1.14 Cell Signaling Technology (US)
10.1.15 Enzo Life Sciences (US)
10.1.16 Master Diagnóstica (Spain)
10.1.17 TissueGnostics (Austria)
10.1.18 Bio SB (US)
10.1.19 MedImmune (US)
10.1.20 Cernostics (US)
10.2 Tissue Diagnostics Instrument Sales Date of Major Players (2017-2020e)
10.2.1 Roche (Switzerland)
10.2.2 Danaher (US)
10.2.3 Thermo Fisher Scientific (US)
10.2.4 Abbott (US)
10.2.5 Agilent Technologies (US)
10.2.6 Merck (Germany)
10.2.7 Sakura Finetek Japan (Japan)
10.2.8 Abcam (UK)
10.2.9 BD (US)
10.2.10 QIAGEN (Netherlands)
10.2.11 Sienna Cancer Diagnostics (Australia)
10.2.12 Royal Philips (Netherlands)
10.2.13 A. Menarini Diagnostics (Italy)
10.2.14 Cell Signaling Technology (US)
10.2.15 Enzo Life Sciences (US)
10.2.16 Master Diagnóstica (Spain)
10.2.17 TissueGnostics (Austria)
10.2.18 Bio SB (US)
10.2.19 MedImmune (US)
10.2.20 Cernostics (US)
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Tissue Diagnostics Instrument Product Type Overview
2.Table Tissue Diagnostics Instrument Product Type Market Share List
3.Table Tissue Diagnostics Instrument Product Type of Major Players
4.Table Brief Introduction of Roche (Switzerland)
5.Table Brief Introduction of Danaher (US)
6.Table Brief Introduction of Thermo Fisher Scientific (US)
7.Table Brief Introduction of Abbott (US)
8.Table Brief Introduction of Agilent Technologies (US)
9.Table Brief Introduction of Merck (Germany)
10.Table Brief Introduction of Sakura Finetek Japan (Japan)
11.Table Brief Introduction of Abcam (UK)
12.Table Brief Introduction of BD (US)
13.Table Brief Introduction of QIAGEN (Netherlands)
14.Table Brief Introduction of Sienna Cancer Diagnostics (Australia)
15.Table Brief Introduction of Royal Philips (Netherlands)
16.Table Brief Introduction of A. Menarini Diagnostics (Italy)
17.Table Brief Introduction of Cell Signaling Technology (US)
18.Table Brief Introduction of Enzo Life Sciences (US)
19.Table Brief Introduction of Master Diagnóstica (Spain)
20.Table Brief Introduction of TissueGnostics (Austria)
21.Table Brief Introduction of Bio SB (US)
22.Table Brief Introduction of MedImmune (US)
23.Table Brief Introduction of Cernostics (US)
24.Table Products & Services of Roche (Switzerland)
25.Table Products & Services of Danaher (US)
26.Table Products & Services of Thermo Fisher Scientific (US)
27.Table Products & Services of Abbott (US)
28.Table Products & Services of Agilent Technologies (US)
29.Table Products & Services of Merck (Germany)
30.Table Products & Services of Sakura Finetek Japan (Japan)
31.Table Products & Services of Abcam (UK)
32.Table Products & Services of BD (US)
33.Table Products & Services of QIAGEN (Netherlands)
34.Table Products & Services of Sienna Cancer Diagnostics (Australia)
35.Table Products & Services of Royal Philips (Netherlands)
36.Table Products & Services of A. Menarini Diagnostics (Italy)
37.Table Products & Services of Cell Signaling Technology (US)
38.Table Products & Services of Enzo Life Sciences (US)
39.Table Products & Services of Master Diagnóstica (Spain)
40.Table Products & Services of TissueGnostics (Austria)
41.Table Products & Services of Bio SB (US)
42.Table Products & Services of MedImmune (US)
43.Table Products & Services of Cernostics (US)
44.Table Market Distribution of Major Players
45.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
46.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
47.Table Global Tissue Diagnostics Instrument Market Forecast (Million USD) by Region 2021f-2026f
48.Table Global Tissue Diagnostics Instrument Market Forecast (Million USD) Share by Region 2021f-2026f
49.Table Global Tissue Diagnostics Instrument Market Forecast (Million USD) by Demand 2021f-2026f
50.Table Global Tissue Diagnostics Instrument Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
